Medicinal product containing the active substance BELIMUMAB

Summary

The tender concerns a framework purchase agreement for the supply of medicinal products containing the active substance belimumab, according to the contracting authority’s needs. The notice shows that e-invoicing and an electronic process are required. The tender is open, the estimated value is CZK 22,625,000, and the deadline for tenders is 4 June 2026 at 09:00.